Journal of Cancer Prevention

eISSN 2288-3657
pISSN 2288-3649

Cited by CrossRef (14)

  1. Anupama Sekhar, P. Veena, Rahul Dhodapkar, Rajesh Nachiappa Ganesh. Prevalence of High-Risk HPV Among Women with Abnormal Pap Smears—A Hospital Based Cross-Sectional Analytical Study. Indian J Gynecol Oncolog 2024;22
    https://doi.org/10.1007/s40944-023-00795-5
  2. Karima Abounouh, Imane Aitraise, Anas Benabou, Ikhlass Boussakri, Mohamed Amine Doumir, Chaimaa El Boussairi, Soukaina El Idrissi, Chaimae El Mahdaoui, Dalal El Qouar, Afaf Ennahal, Sofia Fathi, Maria Hafidi, Lamyae Lachker, Chorouk Ratib, Ikram-Allah Tanouti, Abderrahmane Maaroufi, Soumaya Benjelloun, Fadila Guessous, Pascal Pineau, Sayeh Ezzikouri. Virus-associated human cancers in Moroccan population: From epidemiology to prospective research. Infection, Genetics and Evolution 2019;75:103990
    https://doi.org/10.1016/j.meegid.2019.103990
  3. Suzana Mlinar. Knowledge and awareness of nursing students regarding human papillomaviruses infection and vaccination. VSP 2022;79:890
    https://doi.org/10.2298/VSP200727058M
  4. Tuukka Veija, Virve Koljonen, Tom Bohling, Mia Kero, Sakari Knuutila, Virinder Kaur Sarhadi. Aberrant expression of ALK and EZH2 in Merkel cell carcinoma. BMC Cancer 2017;17
    https://doi.org/10.1186/s12885-017-3233-5
  5. Queenie Fernandes, Soumaya Allouch, Ishita Gupta, Ibrahim Elmakaty, Khaled E. Elzawawi, Ahmed Amarah, Hamda Al-Thawadi, Halema Al-Farsi, Semir Vranic, Ala-Eddin Al Moustafa. Human Papillomaviruses-Related Cancers: An Update on the Presence and Prevention Strategies in the Middle East and North African Regions. Pathogens 2022;11:1380
    https://doi.org/10.3390/pathogens11111380
  6. Kalyani Raju, C. V. Raghuveer, S. R. Sheela, Arvind Natarajan, T. V. Jagadish, B. N. Sunil, B. Sharat. Evaluation of enzyme-linked immunosorbent assay plasma p16INK4a protein in squamous cell carcinoma in uterine cervix. 2022;18:152
    https://doi.org/10.4103/jcrt.JCRT_1290_20
  7. Wei Chen, Liang Tu. Expression and clinical significance of MCM5 and P16 in hyperplastic disease of the cervix. 2018;4:13
    https://doi.org/10.1007/s10330-018-0257-7
  8. Hina Sarwath, Devendra Bansal, Nazik Elmalaika Husain, Mahmoud Mohamed, Ali A. Sultan, Shahinaz Bedri. Introduction of p16INK4a as a surrogate biomarker for HPV in women with invasive cervical cancer in Sudan. Infect Agents Cancer 2017;12
    https://doi.org/10.1186/s13027-017-0159-0
  9. Shandra Devi Balasubramaniam, Venugopal Balakrishnan, Chern Ein Oon, Gurjeet Kaur. Key Molecular Events in Cervical Cancer Development. Medicina 2019;55:384
    https://doi.org/10.3390/medicina55070384
  10. Mehenaz Hanbazazh, Kymberly A. Gyure. Ocular Human Papillomavirus Infections. 2018;142:706
    https://doi.org/10.5858/arpa.2017-0571-RA
  11. Abderrahman Arechkik, Laila Lahlou, Majdouline Obtel, Ahmed Kharbach, Rachid Razine. Cervical cancer in Morocco: A systematic review. Revue d'Épidémiologie et de Santé Publique 2022;70:230
    https://doi.org/10.1016/j.respe.2022.05.008
  12. Arif Ahmad, Mohammad Raish, Mohammad Shahid, Swaraj Batra, Vineeta Batra, Syed Akhtar Husain. The synergic effect of HPV infection and epigenetic anomaly of the p16 gene in the development of cervical cancer. CBM 2017;19:375
    https://doi.org/10.3233/CBM-160060
  13. Dalibor V. Jovanovic, Slobodanka L. Mitrovic, Milos Z. Milosavljevic, Milena B. Ilic, Vesna D. Stankovic, Milena S. Vuletic, Milica N. Dimitrijevic Stojanovic, Danijela B. Milosev, Goran L. Azanjac, Vladica M. Nedeljkovic, Dragce Radovanovic. Breast Cancer and p16: Role in Proliferation, Malignant Transformation and Progression. Healthcare 2021;9:1240
    https://doi.org/10.3390/healthcare9091240
  14. Thabiso Victor Miya, Doreen Ramogola-Masire, Guy Roger Gaudji, Zilungile Lynette Mkhize-Kwitshana, Victoria P. Perepelitsa, Rodney Hull, Zodwa Dlamini. Strategies for Overcoming Chemotherapy Resistance in Cervical Cancer. 2021.
    https://doi.org/10.1016/B978-0-443-28985-9.00011-2
© Korean Society of Cancer Prevention. / Powered by INFOrang Co., Ltd